In this episode, Prof Chapman cuts through the tests and treatments marketed to women after recurrent miscarriage and asks a simple question: where's the evidence? He unpacks the $1,500 endometrial receptivity test shown to have no benefit, the pivot to microbiome testing, and immune treatments sold without solid proof — while separating what's genuinely useful from what he calls "bad medicine." The reframe that matters most: even after four losses, the odds of carrying a baby next time, doing nothing, are still well over 60 to 70%.
Explore the 'Prof. Michael Chapman - The IVF Journey' Facebook Page, your reliable destination for cutting-edge insights and guidance within
the realm of In Vitro Fertilization (IVF).
Don't miss out on the IVF Journey podcast; stay informed with the latest episode updates. Tune in for expert discussions and valuable information on navigating the intricate path of IVF.
